Adherium’s Smartinhaler selected for multisite study in EU

Melbourne, Australia-based smart inhaler company Adherium has been selected to supply the technology for a multi-country research program in Europe that will seek to establish whether home monitoring and mobile health tools can be used to manage asthma.

Adherium’s Smartinhaler technology, which uses sensors to track when medication is taken and then sends the data via Bluetooth to mobile devices and desktop computers, will power the EU’s myAirCoach program, a multisite study funded under the EU’s Horizon 2020 Framework for Research and Innovation initiative.  For the next year, the Smartinhaler will be used at Imperial College London, University of Manchester, and Leiden University Medical Center to help patients manage their condition.  The project is coordinated by the Center for Research and Technology in Greece.

Click here to read the full article.